瓶颈
吞吐量
药物发现
工作流程
计算机科学
生产力
数据科学
嵌入式系统
生物信息学
生物
电信
数据库
宏观经济学
经济
无线
作者
Mark Jones,Ross L. Goodyear
标识
DOI:10.1021/acsmedchemlett.3c00073
摘要
With the "low hanging fruit" of early drug discovery gone, pharmaceutical companies are increasingly turning to developing high-throughput synthetic platforms capable of greatly shortening the design-make-test cycle of new drugs. Purification has long been considered the bottleneck of this procedure; however, new technologies and systems are now being integrated into these high-throughput synthetic workflows, providing compounds of high purity capable of being used directly in biological screening.
科研通智能强力驱动
Strongly Powered by AbleSci AI